OCT Clinical is a leading contract research organization in Eastern Europe, now operating as palleos healthcare. Since 2005, their team has conducted over 300 clinical trials in Europe and the CIS region, offering a full range of high-quality CRO services for Phase I-IV and BE studies. With a focus on therapeutic expertise in oncology, infectious disease, and all major therapeutic indications, OCT has positioned itself as one of the top contract research organizations globally. Their services encompass clinical study design preparation, medical writing, consulting, regulatory support, project management, monitoring, drug safety, pharmacovigilance, data management, biostatistics, clinical supply services and logistics, as well as marketing authorization and GMP inspection support. Headquartered in Germany, OCT Clinical has not disclosed its last investment details. As pharmaceutical and biotechnology companies increasingly adopt outsourcing models in clinical research, OCT's strong local expertise and commitment to quality place it in a favorable position for further growth and expansion.
There is no investment information
No recent news or press coverage available for OCT Clinical.